🇰🇷 South Korea Country × Condition
fallopian tube cancer Clinical Trials in South Korea
Active clinical trials for fallopian tube cancer with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT05912972
Recruiting
Development and Management of Registry in Patients With Gynecologic Cancer in Korea
Enrollment
13,500 pts
Country
🇰🇷 South Korea
Asan Medical Center
View Trial → NCT06787612 Phase 2
Recruiting
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Enrollment
220 pts
Country
🇰🇷 South Korea
Regeneron Pharmaceuticals
View Trial → Frequently Asked Questions
How many fallopian tube cancer clinical trials are active in South Korea?
There are currently 2 active clinical trials for fallopian tube cancer with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a fallopian tube cancer clinical trial in South Korea?
To join a fallopian tube cancer clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are fallopian tube cancer trials in South Korea?
Active fallopian tube cancer trials in South Korea span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology